Tumor Genetics Are Thrombogenic: The Need for Action

JACC CardioOncol. 2023 Apr 18;5(2):256-258. doi: 10.1016/j.jaccao.2023.03.002. eCollection 2023 Apr.

Isabelle Mahé^{1

2

3

4}, Florian Scotté⁵, Ismail Elalamy^{4

6

7}

¹ Université Paris Cité, Paris, France.
² Assistance Publique des Hôpitaux de Paris, Hôpital Louis Mourier, Médecine Interne, Colombes, France.
³ Innovative Therapies in Haemostasis, INSERM UMR_S1140, Paris, France.
⁴ INNOVTE, FCRIN, France.
⁵ Gustave Roussy, Patient Pathway Department, Villejuif, France.
⁶ Hematology and Thrombosis Center, Hôpital Tenon, Hôpitaux Universitaires de l'Est Parisien, Assistance Publique Hôpitaux de Paris, Faculté de Médecine, Sorbonne Université, Paris, France.
⁷ Research Group "Cancer, Vessel Biology and Therapeutics," INSERM U938, Centre de Recherche Saint-Antoine, Institut Universitaire de Cancérologie, Faculty of Medicine, Sorbonne University, Paris, France.

No abstract available

Keywords: arterial thrombosis; cancer; gene; genetic; mutation; venous thrombosis.

Publication types